ACD PHARMACEUTICALS AS: årsregnskap 2018 vs 2017
Grew 61% on revenue
approved 2019-04-29; registry 2019-06-24; journal 2019 507565
Summary
What changed
Comparing Årsregnskap 2018 with 2017 for ACD PHARMACEUTICALS AS. Revenue 12.06m NOK → 19.46m NOK (+61.4%). Equity 2.20m NOK → 2.34m NOK.
On the constructive side: revenue rose; equity strengthened. Pressures included: cash fell.
Also worth watching: payroll increased; cogs moved. All figures are taken from the published annual accounts for ACD PHARMACEUTICALS AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 12.06m NOK to 19.46m NOK (+61.4% YoY). Calculated
-
↑
Equity strengthened
Book equity 2.20m NOK → 2.34m NOK (equity ratio 16.5% → 12.7%). Calculated
What deteriorated
-
↓
Cash fell
Bank deposits 173.6k NOK → 162.9k NOK (-6.2% YoY). Calculated
Things to notice
-
·
Payroll increased
Salary cost 2.68m NOK → 4.21m NOK (22% → 22% of revenue). Calculated
-
·
COGS moved
COGS / varekostnad 3 201 NOK → 335.4k NOK (+10377.9% YoY). Calculated